Clinical Trial Update: Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study) [Phase 4]

View source ↗

Summary

Phase 4 trial update on a treat-and-extend regimen of aflibercept for diabetic macular edema ( VIBIM study ).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Macular Edema, Diabetic | Phase 4 | Status: UNKNOWN